(Q61636083)
Statements
Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis (English)
T I Shireman
P E Hilsenrath
R G Strauss
scientific article published on 01 June 1994
No description defined